title: [Familial hypercholesterolemia in the Czech Republic in 2016].
abstract: Familial hypercholesterolemia (FH) is the most frequent autosomal dominant hereditary disease which is characterized by a decreased LDL-cholesterol catabolism and early clinical manifestation of atherosclerosis affecting blood vessels. The MedPed (Make early diagnosis to Prevent early deaths) project aims to diagnose patients with FH as early as possible, so that they can profit the most from a therapy started in a timely manner and avoid premature cardiovascular events. Currently, as of 31 October 2016, the Czech national database keeps records of 6 947 patients with FH from 5 223 families. Considering the prevalence of FH equalling 1 : 250, this represents 17.4 % of the overall expected number of patients with FH in the Czech Republic. Determining the mutation responsible for FH, now using a next generation sequencing technology in the Czech Republic, brings with it higher diagnostic accuracy, better cooperation of patients and in particular facilitation of cascade screening in families. Although we are among the most successful countries in the world with regard to FH detection, the majority of patients are still undiagnosed. Moreover, as it turns out, most FH patients do not reach the target values with the current therapeutic possibilities. In this regard the newly approved hypolipidemic drugs, PCSK9 inhibitors, to be hopefully available also in the Czech Republic in the near future for chosen patients with FH at high risk, hold great promise.Key words: cascade screening - familial hypercholesterolemia - LDL-cholesterol - MedPed.
authors.forename: Tomáš
authors.initials: T
authors.lastname: Freiberger
authors.forename: Martina
authors.initials: M
authors.lastname: Vaclová
authors.forename: Lukáš
authors.initials: L
authors.lastname: Tichý
authors.forename: Vladimír
authors.initials: V
authors.lastname: Soška
authors.forename: Vladimír
authors.initials: V
authors.lastname: Bláha
authors.forename: Lenka
authors.initials: L
authors.lastname: Fajkusová
authors.forename: Richard
authors.initials: R
authors.lastname: Češka
authors.forename: Michal
authors.initials: M
authors.lastname: Vrablík
mesh_terms: D050197:Atherosclerosis / Q000517:prevention & control; D008078:Cholesterol, LDL / Q000097:blood; D018153:Czech Republic; D016208:Databases, Factual; D042241:Early Diagnosis; D059014:High-Throughput Nucleotide Sequencing; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008403:Mass Screening; D009154:Mutation
chemical_list: D008078:Cholesterol, LDL; D000960:Hypolipidemic Agents